作者
Syed Saif Abbas Rizvi, Jothika Challapalli, Elizabeth J Maynes, Matthew P Weber, Jae Hwan Choi, Thomas J O'Malley, John W Entwistle, Rohinton J Morris, Louis E Samuels, H Todd Massey, Vakhtang Tchantchaleishvili
发表日期
2020/4/1
来源
Transplantation Reviews
卷号
34
期号
2
页码范围
100517
出版商
WB Saunders
简介
Background
Combined heart-liver transplantation (CHLT) has become a viable option for treating concomitant heart and liver failure. However, data are lacking with respect to long-term outcomes.
Methods
An electronic search was performed to identify all studies on CHLT. Following application of inclusion and exclusion criteria, a total of seven studies consisting of 99 CHLT patients were included from the original 1864 articles.
Results
CHLT recipient mean age was 53.0 years (95% CI 48.0–58.0), 67.5% of which (95% CI 56.5–76.9) were male. 65.5% (95% CI 39.0–85.0) of patients developed heart failure due to amyloidosis whereas 21.6% (95% CI 12.3–35.2) developed heart failure due to congenital causes. The most common indication for liver transplant was amyloidosis [65.5% (95% CI 39.0–85.0)] followed by liver failure due to hepatitis C [13.8% (95% CI 2.1–54.4)]. The mean intensive care unit length of stay …
学术搜索中的文章
SSA Rizvi, J Challapalli, EJ Maynes, MP Weber… - Transplantation Reviews, 2020